Huang, J., Song, D., Xu, M., Gan, K., Wang, C., Chen, L., . . . Liu, Q. (2024). Trifolirhizin reduces osteoclast formation and prevents inflammatory osteolysis by inhibiting RANKL‐induced activation of NF‐κB and MAPK signaling pathways and ROS. Wiley. https://doi.org/10.1002/ptr.8299
Chicago Style (17th ed.) CitationHuang, Jian, et al. Trifolirhizin Reduces Osteoclast Formation and Prevents Inflammatory Osteolysis by Inhibiting RANKL‐induced Activation of NF‐κB and MAPK Signaling Pathways and ROS. Wiley, 2024. https://doi.org/10.1002/ptr.8299.
MLA (9th ed.) CitationHuang, Jian, et al. Trifolirhizin Reduces Osteoclast Formation and Prevents Inflammatory Osteolysis by Inhibiting RANKL‐induced Activation of NF‐κB and MAPK Signaling Pathways and ROS. Wiley, 2024. https://doi.org/10.1002/ptr.8299.